View Press Releases
-
Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials
Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials
Apr 1, 2024
-
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.
Apr 1, 2024
-
New study explores how Switzerland can maintain its leading position in life science innovation
The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market.
Apr 1, 2024
-
Integrated DNA Technologies Unveils New Custom Vector Onboarding Tool to Optimize Gene Synthesis
Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool.
Mar 26, 2024
-
North Carolina Takes the Lead in PFAS Research with Collaboratory's $3 Million Investment to Expand the State's Research Capacity
-
One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis
One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments
Mar 25, 2024
-
Illumina Throws Weight Behind National Initiative to Assess Potential of Exhaustive Genomic Profiling in Advanced Cancer Real-World Scenario Across Belgium
-
SIRIO launches personalised women’s health platform at Vitafoods Europe
New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.
Mar 25, 2024
-
Phastar’s Clinical Intelligence Portal Shortlisted as Finalist in 2024 Citeline Award
Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.
Mar 24, 2024
-
CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards
CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.
Mar 24, 2024
-
Visit Watson-Marlow Fluid Technology Solutions at booth 3521 during INTERPHEX 2024 for exclusive technology previews and insights
Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA.
Mar 24, 2024
-
FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering a support package worth over £50K
Discovery Park, Kent’s thriving life science community, has launched a special edition of their growth and support programme, Discovery Spark, for start-ups in FemTech and Women’s Health. Now open for applications, the programme offers tailored mentoring and support for start-ups, preparing founders for success in investment pitches. Companies will compete to win a support package worth over £50K, including 1 year of lab or office space at Discovery Park, alongside invaluable support from healthcare partners, Barclays Eagle Labs and six specialist prize partners.
Mar 21, 2024
-
CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency
-
Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber
-
New Study Links Patients with Multiple Phenotypes to Higher Body Weight and BMI
Research from Mayo Clinic published in Nature’s International Journal of Obesity introduces new insights into obesity precision medicine for patients with more than one phenotype.
Mar 13, 2024
-
Phreesia Announces Jack Callahan as New Chief Technology Officer
Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
Mar 20, 2024
-
ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor
Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery
Mar 20, 2024
-
Alfa Chemistry's MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing
-
ResultsCX Named ‘Promising Provider’ in Everest Group’s Service Provider Compass™ – Global Services Delivery from Mexico Report
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production